Bio-Rad Laboratories Inc. (BIO) Next Earnings Date & Options-Implied ±7% Move
Bio-Rad Laboratories Inc. (BIO) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (59/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+124.3% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Options-Implied Post-Earnings ±7% Bell Curve
Will BIO Beat & Rip or Miss Next Quarter?
Trailing EPS: $28.42 • YoY Revenue Growth: 0.7%
Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence
| Period | Filed | Revenue | Net Profit | Free Cash Flow | Gross Margin |
|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.58B | $759.9M | $374.6M | 51.9% |
| FY 2024 | 2024-12-31 | $2.57B | -$1.84B | $289.6M | 53.7% |
| FY 2023 | 2023-12-31 | $2.67B | -$637.3M | $254.7M | 44% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring BIO)
- ✓Live walkthrough of BIO's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
BIO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +0.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BIO today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BIO. Explore sector supply chains on /butterfly.
BIO Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is BIO's next earnings date?
Based on SEC filing cadence, Bio-Rad Laboratories Inc. (BIO)'s next quarterly earnings window is estimated around Dec 30, 2026.
How much is BIO stock expected to move on earnings?
Options markets currently imply a ±7% post-earnings move for BIO, projecting a trading range between $357.49 and $411.31.